Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Gibraltar Industries Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Gibraltar Industries (NASDAQ:ROCK) earned $15.46 million, a 65.09% increase from the preceding quarter. Gibraltar Industries's sales decreased to $317.87 million, a 4.96% change since Q4.

Benzinga

As Nvidia Stock Slides, Here's How To Play The Counter-Trend

NVIDIA Corporation (NASDAQ: NVDA) plunged over 6% during Wednesday’s trading session in sympathy with the S&P 500, which shed 4%.

Benzinga

Expert Ratings for Argo Blockchain

Within the last quarter, Argo Blockchain (NASDAQ:ARBK) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Replimune Group: Q4 Earnings Insights

Replimune Group (NASDAQ:REPL) reported its Q4 earnings results on Thursday, May 19, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Replimune Group missed estimated earnings by 3.45%, reporting an EPS of $-0.6 versus an estimate of $-0.58.

Benzinga

Expert Ratings for Aptinyx

Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings:

Benzinga

Executives Buy Around $17M Of 5 Penny Stocks

The Nasdaq Composite index tumbled by more than 550 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their…

Benzinga

Why Cisco Systems Stock Is Falling Today

Cisco Systems Inc (NASDAQ: CSCO) shares are trading lower Thursday after the company reported worse-than-expected top-line results and issued guidance below analyst estimates.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Morning Brief: Top Financial Stories Dominating on Thursday, May 19

CNBC CDC Looking Into 180 Cases Of Unexplained Pediatric Acute Hepatitis

Benzinga

10 Biggest Price Target Changes For Thursday

Telsey Advisory Group cut the price target for Bath & Body Works, Inc. (NYSE: BBWI) from $70 to $60. Bath & Body Works shares fell 6.9% to $40.00 in pre-market trading.

Benzinga

Recap: Nano X Imaging Q1 Earnings

Nano X Imaging (NASDAQ:NNOX) reported its Q1 earnings results on Thursday, May 19, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Children's Place: Q1 Earnings Insights

Children's Place (NASDAQ:PLCE) reported its Q1 earnings results on Thursday, May 19, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Cannabis Movers & Shakers: Flora Growth, Valens, Metrc, Treez

Flora Growth Welcomes Cannabis Regulatory Veteran Holly Bell As VP Of Regulatory Affairs Flora Growth Corp. (NASDAQ: FLGC) has tapped regulatory veteran Holly Bell to serve as vice president of regulatory affairs.

Benzinga

HubSpot And 2 Other Stocks Insiders Are Buying

Although the Dow Jones dipped sharply by over 1,150 points on Wednesday, there were a few notable insider trades.

Benzinga

Why Cathie Wood Says Record-Breaking Inventories Could Lead To Weaker Prices

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mersana Stock Gains On FDA Orphan Drug Designation For Gastric Cancer Drug

Mersana Therapeutics, Inc. (NASDAQ: MRSN) received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its drug candidate XMT-2056 or the treatment of gastric cancer. The company is planning to start a clinical study evaluating XMT-2056 for gastric and other cancers.

Benzinga

The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

G Medical Warns On Missing Q1 Sales Guidance Of $30M

G Medical Innovations Holdings Ltd (NASDAQ:GMVD) said that it would not meet its forecast of $30 million in revenues in Q1 of 2022. The company said that the previously reported purchase orders from McDade Products LLC for 6 million co-branded LiveNow COVID-19 PCR Test Collection Kits (approximately $20 million in orders) have not materialized into…

Benzinga

'Ridiculous,' 'Wacktivism:' Cathie Wood, Elon Musk React To Tesla's Removal From S&P 500 ESG Index

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Apple Faces Lawsuit Over Allegedly Forcing Workers To Attend Anti-Union Speeches

Apple, Inc. (NASDAQ: AAPL) seems to have ruffled the feathers of the largest union of communication workers in the U.S. even as it strives to win over its retail store employees.

Benzinga

More Bearish Bets For Costco Wholesale

Amid the broader retail bloodbath on Wednesday, shares of Costco Wholesale Corporation (NASDAQ: COST) tanked more than 12% in their worst performance since 2003.

Benzinga

Cramer Shares His Thoughts On BioNTech, Vertex Energy And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Veru Inc. (NASDAQ: VERU) is "up a great deal … we caught it much lower."

Benzinga

Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock

Ark Investment Management, led by Tesla Inc.

Benzinga

Vietnam PM Met Apple CEO Tim Cook During Recent US Visit To Discuss Manufacturing

During his recent visit to the United States, Vietnamese Prime Minister Pham Minh Chinh made a visit to Silicon Valley tech giants including Apple Inc (NASDAQ: AAPL) to discuss business, according to

Benzinga

24 Stocks Moving in Thursday's Pre-Market Session

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares rose 20.9% to $0.70 in pre-market trading after dropping 12% on Wednesday. Acorda Therapeutics recently posted a Q1 loss of $1.66 per share.

Benzinga

Netflix Said To Be Rapidly Losing Support From Longtime Subscribers

Netflix Inc's (NASDAQ: NFLX) troubles seem to be running deeper. The streaming giant is reportedly losing the support of its longtime subscribers as it tries to pull out all the stops to turn around its fortunes.

1 … 509 510 511 512

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.